Molecular profiling of melanoma tumor biopsies to identify a response signature to the multi-RTK inhibitor, E7080

8595 Background: E7080 is an oral TKI targeting VEGFR1-3, FGFR1-4, PDGFRβ, RET and KIT, which affects tumor cell proliferation and tumor vascularization in laboratory models. Tumor response (RECIST...